Extracorporeal life support provision in COVID-19 patients - An international EuroELSO 2022 update survey.
Marcel FleigThomas MüllerMarta Velia AntoniniJordi RieraMirko BelliatoLars Mikael BromanJo-Anne FowlesJan BelohlavekRoberto LorussoLeen VercaemstTim JonesPeter Paul RoeleveldMatteo Di NardoNicholas A BarrettJustyna SwolPublished in: Perfusion (2023)
Majority of the COVID-19 patients received respiratory ECLS support and adult patients dominated. The indications and contraindications are broadly aligned with available guidelines. Most of the centers considered age >65 or biological age as a relative or absolute contraindication for ECLS in COVID-19. ECLS withdrawal criteria in COVID-19 are controversial because the long-term outcomes after ECLS in COVID-19 and the impact of critical illness and the impact of long-COVID are still not known.